SYDNEY GIVENS: Open Payments
NPI 1992236889 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 38 payments from 8 companies in 2025. Trend: 2023 $230 · 2024 $731 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $299 |
| Janssen Biotech, Inc. | 6 | $295 |
| UCB, Inc. | 11 | $165 |
| GENZYME CORPORATION | 2 | $49 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $19 |
Products named: TREMFYA, SKYRIZI, Bimzelx, BOTOX, DUPIXENT, Winlevi, COSENTYX, EBGLYSS.
Industry payments across AL — which companies pay providers there.
